Table 4.

The specificity of individual markers and uRNA-D

Test negatives/total true negatives* (%)
MDKCDC2IGFBP5HOXA13uRNA-D
Urinary tract infections16/20 (80%)15/20 (75%)17/20 (85%)20/20 (100%)16/20 (80%)
Other benign urinary tract disease21/24 (88%)22/24 (92%)21/24 (88%)19/24 (79%)20/24 (83%)
Other urological cancers29/33 (88%)29/33 (88%)28/33 (85%)27/33 (82%)30/33 (91%)
Overall85%85%85%85%85%
  • * True negatives were defined as samples from patients who were negative for TCC by flexible cystoscopy.